Systemic lupus erythematosus

被引:628
作者
D'Cruz, David P. [1 ]
Khamashta, Munther A. [1 ]
Hughes, Graham R. V. [1 ]
机构
[1] St Thomas Hosp, Rayne Inst, Lupus Res Unit, London SE1 7EH, England
关键词
D O I
10.1016/S0140-6736(07)60279-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic lupus erythematosus is an autoimmune connective-tissue disorder with a wide range of clinical features, which predominantly affects women, especially from certain ethnic groups. Diagnosis is based on clinical assessment supported by investigations, including the finding of autoantibodies. Treatments range from antimalarial agents to corticosteroids and immunosuppressive agents. This Seminar draws attention to advances in the epidemiology, genetics, cardiovascular risks, lupus nephritis, CNS disease, the antiphospholipid syndrome, assessment of disease activity and damage, and pregnancy related and quality of life issues. New therapeutic approaches, such as biological agents and mycophenolate mofetil, will also be discussed.
引用
收藏
页码:587 / 596
页数:10
相关论文
共 94 条
[1]   The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus [J].
Anolik, JH ;
Campbell, D ;
Felgar, RE ;
Young, F ;
Sanz, I ;
Rosenblatt, J ;
Looney, RJ .
ARTHRITIS AND RHEUMATISM, 2003, 48 (02) :455-459
[2]   Development of autoantibodies before the clinical onset of systemic lupus erythematosus [J].
Arbuckle, MR ;
McClain, MT ;
Rubertone, MV ;
Scofield, RH ;
Dennis, GJ ;
James, JA ;
Harley, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (16) :1526-1533
[3]   Premature coronary-artery atherosclerosis in systemic lupus erythematosus [J].
Asanuma, Y ;
Oeser, A ;
Shintani, AK ;
Turner, E ;
Olsen, N ;
Fazio, S ;
Linton, MF ;
Raggi, P ;
Stein, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (25) :2407-2415
[4]   Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines [J].
Asherson, RA ;
Cervera, R ;
de Groot, PG ;
Erkan, D ;
Boffa, MC ;
Piette, JC ;
Khamashta, MA ;
Shoenfeld, Y .
LUPUS, 2003, 12 (07) :530-534
[5]  
ASHERSON RA, 1990, J RHEUMATOL, V17, P1292
[6]   Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome:: preliminary data [J].
Barón, MA ;
Khamashta, MA ;
Hughes, GRV ;
D'Cruz, DP .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (01) :144-146
[7]   An International Cohort Study of Cancer in Systemic Lupus Erythematosus [J].
Bernatsky, S ;
Boivin, JF ;
Joseph, L ;
Rajan, R ;
Zoma, A ;
Manzi, S ;
Ginzler, E ;
Urowitz, M ;
Gladman, D ;
Fortin, PR ;
Petri, M ;
Edworthy, S ;
Barr, S ;
Gordon, C ;
Bae, SC ;
Sibley, J ;
Isenberg, D ;
Rahman, A ;
Aranow, C ;
Dooley, MA ;
Steinsson, K ;
Nived, O ;
Sturfelt, G ;
Alarcón, G ;
Senécal, JL ;
Zummer, M ;
Hanly, J ;
Ensworth, S ;
Pope, J ;
El-Gabalawy, H ;
McCarthy, T ;
Pierre, YS ;
Ramsey-Goldman, R ;
Clarke, A .
ARTHRITIS AND RHEUMATISM, 2005, 52 (05) :1481-1490
[8]   Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus [J].
Burt, RK ;
Traynor, A ;
Statkute, L ;
Barr, WG ;
Rosa, R ;
Schroeder, J ;
Verda, L ;
Krosnjar, N ;
Quigley, K ;
Yaung, K ;
Villa, M ;
Takahashi, M ;
Jovanovic, B ;
Oyama, Y .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (05) :527-535
[9]   The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus:: A randomized trial [J].
Buyon, JP ;
Petri, MA ;
Kim, MY ;
Kalunian, KC ;
Grossman, J ;
Hahn, BH ;
Merrill, JT ;
Sammaritano, L ;
Lockshin, M ;
Alarcón, GS ;
Manzi, S ;
Belmont, HM ;
Askanase, AD ;
Sigler, L ;
Dooley, MA ;
Von Feldt, J ;
McCune, WJ ;
Friedman, A ;
Wachs, J ;
Cronin, M ;
Hearth-Holmes, M ;
Tan, M ;
Licciardi, F .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (12) :953-962
[10]   Class III-IV proliferative lupus nephritis and pregnancy:: A study of 42 cases [J].
Carmona, F ;
Font, J ;
Moga, I ;
Làzaro, I ;
Cervera, R ;
Pac, V ;
Balasch, J .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2005, 53 (04) :182-188